Betta Pharmaceuticals’ EYP-1901 Implant Secures NMPA Clinical Trial Nod for Wet AMD
Betta Pharmaceuticals (SHE: 300558) has announced that it has received clinical trial approval from China’s...
Company
Shenzhen Tyercan Bio-Pharma’s TYE1001 Earns Tacit IND Approval from FDA for Advanced Solid Tumors
Shenzhen Tyercan Bio-pharm Co., Ltd, a biopharmaceutical company based in China, has announced that it...
Mabwell Bioscience Receives NMPA Approval for Phase II TNBC Clinical Trial of 9MW2821
Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced that China’s National Medical Products Administration...
Lionco Pharmaceutical Partners with Laboratoire Bailly-Creat to Expand Overseas
Shanghai-based Lionco Pharmaceutical Group (SHA: 603669) has entered into a strategic partnership framework agreement with...
Novo Nordisk Faces US Senators’ Scrutiny Over Levemir Withdrawal
US senators, including Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren, have voiced concerns over Novo...
Johnson & Johnson Appoints Edward Zhou as Medtech China President
Johnson & Johnson (J&J, NYSE: JNJ), a global healthcare giant, has announced the appointment of...
Ipsen S.A. Receives NMPA Green Light for Six-Month Diphereline Dosage in Central Precocious Puberty
Ipsen S.A. (EPA: IPN; OTCMKTS: IPSEY) has announced that it has received marketing approval from...
Shanghai HeartCare Medical Secures Taiwan Approval for Homegrown Femoral Artery Occluder
Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609), a leading player in the Chinese medical...
Nona Biosciences Partners with Alaya.bio to Revolutionize CAR-T Therapy Development
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
Eisai’s Next-Gen SERD, Orserdu, Begins Real-World Study in Shanghai Ruijin Hospital’s Hainan Subsidiary
Shanghai Ruijin Hospital’s Hainan subsidiary has initiated a real-world study for Orserdu (elacestrant), a next-generation...
Everest Medicines’ Velsipity Shows Positive Results in Largest Asian Phase III UC Trial
Everest Medicines (HKG: 1952), a leading biopharmaceutical company based in China, has announced positive top-line...
Huadong Medicine’s Partner Arcutis Gets FDA Nod for Roflumilast Cream
Huadong Medicine Co., Ltd (SHE: 000963), a Chinese pharmaceutical company, announced that its co-development partner...
Mindray Bio-Medical Partners with Nanjing Municipal Government to Boost Healthcare Innovation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading player in the global medical...
Shenzhen-Based National Biological Manufacturing Innovation Center Breaks Ground
Construction has commenced on a pioneering national biological manufacturing industry innovation center in Shenzhen, marking...
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured...
Merck KGaA Launches First GMP Cell Culture Medium Production Line in China
German pharmaceutical giant Merck KGaA (ETR: MRK) has announced the commencement of commercial manufacturing of...
AusperBio Secures $37 Million in Series A Funding to Advance Hepatitis B Therapy AHB-137
AusperBio, a sino-American biotechnology company specializing in liver therapy development, has reportedly secured USD 37...
Mabwell Bioscience’s 9MW2821 Earns FDA Fast Track Designation for Triple Negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a biopharmaceutical company based in China, has announced...
Shanghai Duoning Biotechnology Partners with BASF SE to Commercialize Medical Materials in China
Shanghai Duoning Biotechnology Co., Ltd, a prominent player in China’s biopharmaceutical industry, has entered into...
NMPA Accepts 3SBio’s Filing for Anemia Treatment SSS06, Potential Game Changer for Dialysis Patients
3SBio Inc. (HKG: 1530), a leading biopharmaceutical company based in China, has announced that the...